PMOS replaces PCOS in a landmark medical renaming

PMOS renamed – PCOS has been officially renamed PMOS to better reflect the condition’s metabolic and hormonal roots and to correct long-held myths.

A medical label that long shaped both diagnosis and anxiety is changing: polycystic ovary syndrome (PCOS) has now been officially renamed PMOS at the European Congress of Endocrinology in Prague.

Endocrinologist Helena Teede announced that the condition will be known as polyendocrine metabolic ovarian syndrome (PMOS).. For many patients, supporters say the shift is more than symbolic.. It targets a persistent misunderstanding about what doctors see on scans. while also drawing clearer attention to the hormonal and metabolic dimensions of the disorder that extend well beyond the ovaries.

The “cysts” often described in PCOS are not cysts in the way the name can imply.. Dark spots seen on ultrasound have been mischaracterized; they are actually eggs that have not matured fully and have not been released through ovulation.. In this view. the problem is less about harmful cysts and more about development stalling at an intermediate stage—an issue linked to the crowded environment in the ovary when there are many eggs present.

That crowding matters because it can disrupt egg development and normal ovulation.. When ovulation is irregular or absent, menstrual cycles may be irregular or even stop.. It can also make pregnancy take longer, since eggs are released less often for possible fertilisation.. Importantly. research described alongside this change suggests that outcomes can still be similar for many people over time: women with the condition are reported as being as likely to reach their desired family size as those without it. and 80 per cent conceive without medication or IVF.

The renaming also reflects what has become increasingly clear in research: PMOS is not confined to ovarian appearance or fertility alone.. The condition is characterised by high levels of male sex hormones such as testosterone. which can contribute to acne. excess hair growth on the face and body. and thinning hair on the scalp.. Insulin resistance is also common. and it can connect PMOS to weight gain and longer-term health risks including type 2 diabetes. high blood pressure. and heart disease.. Mood symptoms may also occur, with anxiety and depression reported in some people.

While PMOS is often presented as a lifelong challenge, there may be some potential upsides later in adulthood.. A recent study found that a higher egg reserve in people with the condition can delay perimenopause and menopause.. Later menopause is associated with living longer. and the researchers noted it may also allow pregnancies at older ages—an especially meaningful point for anyone trying to plan across decades of care.

Why the condition is so common—reported as affecting about 1 in 8 women—has prompted another line of explanation.. Terhi Piltonen at Oulu University Hospital in Finland. president of the International Androgen Excess and Polycystic Ovary Syndrome Society. suggested an evolutionary possibility: in times when food was scarcer and pregnancy was more dangerous. storing energy as extra weight. spacing pregnancies farther apart. and continuing reproduction at older ages could have offered advantages.. With modern environments that make energy-dense foods more available and with childbirth becoming safer. the balance has shifted. and more problems than benefits tend to emerge.

For patients, much of the impact of the older label comes from what it prompted clinicians and patients to assume.. For years, focus on the ovaries has led many people to seek help mainly when fertility becomes difficult.. Supporters of the renaming argue that PMOS should encourage earlier. wider recognition of hormonal and metabolic symptoms—so care can include symptom management beyond reproductive planning.

The campaign behind this change is also being framed as a long-term effort to align language with science.. Teede. who works at Monash University in Melbourne. has spent 14 years leading the push for a new name and worked with 56 patient and professional organisations to develop one that is scientifically accurate and easier to implement.. Advocates say the goal is to reduce the confusion and worry that can follow diagnosis—especially when scan interpretations have historically led to fears that “cysts” might burst or require emergency surgery.

For many, the promise of the renaming is that it reorients attention without dismissing real symptoms.. Instead of focusing on a feared ovarian finding. PMOS places emphasis on the mechanisms that drive irregular periods. fertility challenges. acne and hair changes. insulin resistance. and cardiovascular and mental health risks.. If the new name helps clinicians and patients see the condition more accurately. supporters argue. the work may ultimately translate into better access to the right kind of help.

MISRYOUM

PMOS PCOS renamed polyendocrine metabolic ovarian syndrome endocrinology insulin resistance reproductive health